|
Disease type | Statin | Target cell/disease | Consequence | Reference |
|
Cancer | Simvastatin | Motoneuron-like NSC34 cells, a model of neuroblastoma | Reduction of autophagic vacuoles and LC3II/I decreased cell survival | [103] |
Simvastatin | Breast cancer cells of MDA-MB-231 | Inhibition of autophagy Reduced survival of breast cancer cells | [86] |
Lovastatin | Malignant mesothelioma ZL55 cancer cells | Stimulation of autophagy Reduced survival of malignant mesothelioma cells | [87] |
Lovastatin | Human malignant pleural mesothelioma ACC-MESO1 cells | Induction of autophagy Decreased survival of malignant pleural mesothelioma | [120] |
Lovastatin | Human malignant peripheral nerve sheath tumor ST88-14 and NF90-8 cells | Perturbation of autophagy flux, induction of nonapoptotic cell death Decreased survival of malignant peripheral nerve sheath tumor cells | [88] |
Atorvastatin | Breast cancer MDA-MB-231 cells | Stimulation of autophagy Inhibition of breast cancer cell proliferation | [92] |
Pitavastatin | Human melanoma WM115 and A375 cells | Induction of autophagy Decreased survival of melanoma cells | [93] |
Rosuvastatin | Human papillary thyroid cancer cells | Suppression of autophagy Induction of apoptosis in papillary thyroid cancer cells | [94] |
|
Osteoarthritis | Simvastatin | Mouse model of OA | Stimulation of autophagy Deceleration of OA progression | [97] |
|
Cardiovascular diseases | Pitavastatin | Cardiomyocyte | Suppression of autophagy Decreased cardiomyocyte injury | [109] |
Simvastatin | Male Sprague-Dawley rat | Suppression of autophagy Decreased cardiomyocyte injury | [111] |
Atorvastatin | Mouse model of atherosclerosis | Stimulation of autophagy Suppression of inflammation Increased stability of vulnerable atherosclerotic plaques | [108] |
Rosuvastatin | Myocardial infarction model rat | Induction of autophagy Improved acute myocardial infarction | [110] |
|
Neurodegenerative diseases | Rosuvastatin | Rotenone-induced neurotoxicity model, PD SH-SY5Y cells | Induction of autophagy Neuroprotective function against PD | [105] |
Atorvastatin, pitavastatin, fluvastatin, pravastatin, simvastatin, and rosuvastatin | In vitro model of lipopolysaccharide- (LPS-) induced neuroinflammation | Suppression of autophagy Neuroprotective function | [106] |
|